Skip to main content
SpringerLink
Log in

PET/CT in Gall Bladder and Biliary Tract Malignancies

  • Chapter
  • First Online:
PET/CT in Hepatobiliary and Pancreatic Malignancies

Part of the book series: Clinicians’ Guides to Radionuclide Hybrid Imaging ((PET/CT))

Abstract

In this chapter we shall discuss the role of positron emission tomography (PET/CT) in biliary tract malignancies—i.e., gall bladder cancer (GBC) and cholangiocarcinoma (CCA). Though carcinoma of ampulla of Vater could also be included here, it will be discussed separately in pancreatic malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Levy AD, Murakata LA, Rohrmann CA Jr. Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics 2001, 21:295–314.

    Google Scholar 

  2. Rodríguez-Fernández A, Gómez-Río M, Medina-Benítez A, Moral JV, Ramos-Font C, Ramia-Angel JM, Llamas-Elvira JM, Ferrón-Orihuela JA, Lardelli-Claret P. Application of modern imaging methods in diagnosis of gallbladder cancer. J Surg Oncol. 2006;93:650–64.

    Article  PubMed  Google Scholar 

  3. Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y, D’Angelica M, Dematteo RP, Blumgart LH, O’Reilly EM. Gallbladder cancer (GBC):10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008;98:485–9.

    Google Scholar 

  4. Agrawal A, Rangarajan V. Appropriateness criteria of FDG PET/CT in oncology. Indian J Radiol Imaging. 2015;25(2):88–101.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Ramos-Font C, Ramos-Font C, Gómez-Rio M, Rodríguez-Fernández A, et al. Ability of FDG-PET/CT in the detection of gallbladder cancer. J Surg Oncol. 2014;109(3):218–24.

    Article  PubMed  Google Scholar 

  6. Leung U, Pandit-Taskar N, Corvera CU, et al. Impact of pre-operative positron emission tomography in gallbladder cancer. HPB (Oxford). 2014;16:1023–30.

    Article  Google Scholar 

  7. Goel M, Tamhankar A, Rangarajan V, Patkar S, Ramadwar M, Shrikhande SV. Role of PET CT scan in redefining treatment of incidental gall bladder carcinoma. J Surg Oncol. 2016;113(6):652–8.

    Article  PubMed  Google Scholar 

  8. Annunziata S, Pizzuto DA, Caldarella C, Galiandro F, Sadeghi R, Treglia G. Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in gallbladder cancer: a meta-analysis. World J Gastroenterol. 2015;21(40):11481–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Hwang JP, Lim I, Na II, et al. Prognostic value of maxSUV measured by fluorine-18 fluorodeoxyglucose positron emission tomography with computed tomography in patients with gallbladder cancer. Nucl Med Mol Imaging. 2014;48(2):114–20.

    Google Scholar 

  10. Yoo J, Choi JY, Lee KT, et al. Prognostic significance of volume-based metabolic parameters by (18)FFDG PET/CT in gallbladder carcinoma. Nucl Med Mol Imaging. 2012;46(3):201–6.

    Article  CAS  PubMed Central  Google Scholar 

  11. Redondo F, Butte J, Lavados H, et al. 18F-FDG PET/CT performance and prognostic value in patients with incidental gallbladder carcinoma. J Nucl Med. 2012;53(515):515.

    Google Scholar 

  12. Blechacz BR, Gores GJ. Cholangiocarcinoma. Clin Liver Dis. 2008;12:131e50.

    Article  Google Scholar 

  13. De Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med. 1999;341:1368e78.

    Article  Google Scholar 

  14. Gores GJ. Early detection and treatment of cholangiocarcinoma. Liver Transpl. 2000;6:S30e4.

    Article  Google Scholar 

  15. Zech CJ, Shoenberg SO, Reiser M, Helmberger T. Cross-sectional imaging of biliary tumors: current clinical status and future developments. Eur Radiol. 2004;14:1174e87.

    Article  Google Scholar 

  16. Kim JY, Kim MH, Lee TY, et al. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging. Am J Gastroenterol. 2008;103:1145–51.

    Article  PubMed  Google Scholar 

  17. Petrowsky H, Wildbrett P, Husarik DB, et al. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol. 2006;45:43–50.

    Article  Google Scholar 

  18. Moon CM, Bang S, Chung JB, Park SW, Song SY, Yun M, et al. Usefulness of 18F- fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas. J Gastroenterol Hepatol. 2008;23:759e65.

    Article  Google Scholar 

  19. Corvera CU, Blumgart LH, Akhurst T, DeMatteo RP, D’Angelica M, Fong Y, et al. 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg. 2008;206:57e65.

    Article  Google Scholar 

  20. Keiding S, Hansen SB, Rasmussen HH, Gee A, Kruse A, Roelsgaard K, et al. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology. 1998;28:700e6.

    Google Scholar 

  21. Anderson CD, Rice MH, Pinson CW, Chapman WC, Chari RS, Delbeke D. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg. 2004;8:90–7.

    Article  Google Scholar 

  22. Kluge R, Schmidt F, Caca K, Barthel H, Hesse S, Georgi P, et al. Positron emission tomography with [18F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology. 2001;33:1029e35.

    Article  Google Scholar 

  23. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224:463–473, discussion 473–475.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Jadvar H, Henderson RW, Conti PS. [F-18]Fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma. J Comput Assist Tomogr. 2007;31:223–8.

    Article  PubMed  Google Scholar 

  25. Kato T, Tsukamoto E, Kuge Y, Katoh C, Nambu T, Nobuta A, et al. Clinical role of [18]F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med. 2002;29:1047e54.

    Google Scholar 

  26. Seo S, Hatano E, Higashi T, Nakajima A, Nakamoto Y, Tada M, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass forming intrahepatic cholangiocarcinoma. Surgery. 2008;143:769e77.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tata Memorial Hospital, Mumbai, Maharashtra, India

    Archi Agrawal, Nilendu Purandare, Sneha Shah, Ameya Puranik & Venkatesh Rangarajan

Authors
  1. Archi Agrawal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nilendu Purandare
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sneha Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ameya Puranik
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Venkatesh Rangarajan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Archi Agrawal .

Editor information

Editors and Affiliations

  1. Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, Mumbai, Maharashtra, India

    Nilendu Purandare

  2. Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, Mumbai, Maharashtra, India

    Sneha Shah

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Agrawal, A., Purandare, N., Shah, S., Puranik, A., Rangarajan, V. (2018). PET/CT in Gall Bladder and Biliary Tract Malignancies. In: Purandare, N., Shah, S. (eds) PET/CT in Hepatobiliary and Pancreatic Malignancies. Clinicians’ Guides to Radionuclide Hybrid Imaging(). Springer, Cham. https://doi.org/10.1007/978-3-319-60507-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-60507-4_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-60506-7

  • Online ISBN: 978-3-319-60507-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation